Basit öğe kaydını göster

dc.contributor.authorGüçlü, Ertuğrul
dc.contributor.authorÖğütlü, Aziz
dc.contributor.authorKarabay, Oğuz
dc.contributor.authorDemirdal, Tuna
dc.contributor.authorErayman, İbrahim
dc.contributor.authorHoşoğlu, Salih
dc.contributor.authorTeker, Bahri
dc.contributor.authorSözen, Hamdi
dc.date.accessioned2020-11-20T14:55:12Z
dc.date.available2020-11-20T14:55:12Z
dc.date.issued2017
dc.identifier.issn1120-009X
dc.identifier.issn1973-9478
dc.identifier.urihttps://doi.org/10.1080/1120009X.2016.1156893
dc.identifier.urihttps://hdl.handle.net/20.500.12809/2215
dc.descriptionWOS: 000396680900004en_US
dc.descriptionPubMed ID: 27238248en_US
dc.description.abstractThis multi-centre study aimed to determine the antibiotic consumption in Turkish hospitals by point prevalence. Antibiotic consumption of 14 centres was determined using the DDD method. Among hospitalized patients, 44.8% were using antibiotics and the total antibiotic consumption was 674.5 DDD/1000 patient-days (DPD). 189.6 (28%) DPD of the antibiotic consumption was restricted while 484.9 (72%) DPD was unrestricted. Carbapenems (24%) and beta lactam/beta lactamase inhibitors (ampicillin-sulbactam or amoxicillin-clavulanate; 22%) were the most commonly used restricted and unrestricted antibiotics. Antibiotics were most commonly used in intensive care units (1307.7 DPD). Almost half of the hospitalized patients in our hospitals were using at least one antibiotic. Moreover, among these antibiotics, the most commonly used ones were carbapenems, quinolones and cephalosporins, which are known to cause collateral damage. We think that antibiotic resistance, which is seen at considerably high rates in our hospitals, is associated with this level of consumption.en_US
dc.item-language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAntibioticen_US
dc.subjectAntibiotic Stewardshipen_US
dc.subjectConsumptionen_US
dc.subjectHospitalen_US
dc.titleAntibiotic consumption in Turkish hospitals; a multi-centre point prevalence studyen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Eğitim ve Araştırma Hastanesien_US
dc.contributor.institutionauthorSözen, Hamdi
dc.identifier.doi10.1080/1120009X.2016.1156893
dc.identifier.volume29en_US
dc.identifier.issue1en_US
dc.identifier.startpage19en_US
dc.identifier.endpage24en_US
dc.relation.journalJournal of Chemotherapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster